While the novel coronavirus COVID-19 relentlessly attacks the lungs of millions, there is one bit of bright news regarding deaths from lung cancer.
UPI reports a new analysis reveals deaths from non-small cell lung cancer in the US declined by about 3% a year on average between 2006 and 2016.
The number of Americans who died from the most common form of lung cancer dropped by 3.2% per year from 2006 through 2013.
From 2013 through 2016, it dropped by 6.3% per year. Experts say the drop is likely due to the increased availability and sophistication of genetic testing.
Between 2001 and 2008, rates of non-small cell lung cancer diagnoses across the country fell by an average of 1.9% annually.